Andrographis
Latin name
Origin
Used part
Active components
Usage
Bibliographical references
- Andrographis paniculata in the treatment of upper respiratory tractinfections: a systematic review of safety and efficacy.
Coon JT, Ernst E.
Planta Med. 2004 Apr;70(4):293-8.
Pubmed: http://www.ncbi.nlm.nih.gov/pubmed/15095142
- Andrographolide: A Review of its Anti-inflammatoryActivity via Inhibition of NF-kappaB Activation from ComputationalChemistry Aspects
Jutti Levita, As`ari Nawawi, Abdul Mutalib and Slamet Ibrahim
International Journal of Pharmacology, 2010, Volume 6, Issue5, Page: 569-576.
Science Alert:http://scialert.net/abstract/?doi=ijp.2010.569.576
- Efficacy of Andrographis paniculata, Nees forpharyngotonsillitis in adults.
Thamlikitkul V, Dechatiwongse T, Theerapong S, Chantrakul C,Boonroj P, Punkrut W, Ekpalakorn W, Boontaeng N, Taechaiya S,Petcharoen S, et al.
J Med Assoc Thai. 1991 Oct;74(10):437-42.
Pubmed: http://www.ncbi.nlm.nih.gov/pubmed/1797953
- Andrographolide prevents oxygen radical production byhuman neutrophils: possible mechanism(s) involved in itsanti-inflammatory effect.
Shen YC, Chen CF, Chiou WF.
Br J Pharmacol. 2002 Jan;135(2):399-406.
Pubmed: http://www.ncbi.nlm.nih.gov/pubmed/11815375
- Antimicrobial activity of Andrographis paniculata.
Singha PK, Roy S, Dey S.
Fitoterapia. 2003 Dec;74(7-8):692-4.
Pubmed: http://www.ncbi.nlm.nih.gov/pubmed/14630176
- Analgesic, antipyretic, anti-inflammatory and toxiceffects of andrographolide derivatives in experimental animals
Supawadee Suebsasana, Panicha Pongnaratorn, JintanaSattayasai, Tarinee Arkaravichien, Siriporn Tiamkao, ChantanaAromdee
Archives of Pharmacal Research September 2009, Volume 32,Issue 9, pp 1191-1200
Springer Link:http://link.springer.com/article/10.1007%2Fs12272-009-1902-x
- Use of visual analogue scale measurements (VAS) to assesthe effectiveness of standardized Andrographis paniculata extractSHA-10 in reducing the symptoms of common cold. A randomized doubleblind-placebo study.
Cáceres DD, Hancke JL, Burgos RA, Sandberg F, Wikman GK.
Phytomedicine. 1999 Oct;6(4):217-23.
Pubmed: http://www.ncbi.nlm.nih.gov/pubmed/10589439
- Immunostimulant agents from Andrographis paniculata.
Puri A, Saxena R, Saxena RP, Saxena KC, Srivastava V, TandonJS.
J Nat Prod. 1993 Jul;56(7):995-9.
Pubmed: http://www.ncbi.nlm.nih.gov/pubmed/8377022
- Antioxidative and cytoprotective effects ofandrographolide against CCl4-induced hepatotoxicity in HepG2 cells.
Krithika R, Verma R, Shrivastav P.
Hum Exp Toxicol. 2012 Sep 27.
Pubmed: http://www.ncbi.nlm.nih.gov/pubmed/23023025
10. Antioxidant and gastroprotective activities ofAndrographis paniculata (Hempedu Bumi) in Sprague Dawley rats.
Wasman SQ, Mahmood AA, Chua LS, Alshawsh MA, Hamdan S.
Indian J Exp Biol. 2011 Oct;49(10):767-72.
Pubmed: http://www.ncbi.nlm.nih.gov/pubmed/22013743
- Antioxidant, antioedema and analgesic activities ofAndrographis paniculata extracts and their active constituentandrographolide.
Lin FL, Wu SJ, Lee SC, Ng LT.
Phytother Res. 2009 Jul;23(7):958-64.
Pubmed: http://www.ncbi.nlm.nih.gov/pubmed/19142986
- A randomized, controlled study of Kan Jang versusamantadine in the treatment of influenza in Volgograd.
Kulichenko LL, Kireyeva LV, Malyshkina EN, Wikman G.
J Herb Pharmacother. 2003;3(1):77-93.
Pubmed: http://www.ncbi.nlm.nih.gov/pubmed/15277072
- Double-blind, placebo-controlled pilot and phase IIIstudy of activity of standardized Andrographis paniculata HerbaNees extract fixed combination (Kan jang) in the treatment ofuncomplicated upper-respiratory tract infection.
Melchior J, Spasov AA, Ostrovskij OV, Bulanov AE, Wikman G.
Phytomedicine. 2000 Oct;7(5):341-50.
Pubmed: http://www.ncbi.nlm.nih.gov/pubmed/11081985 - A randomized double blind placebo controlled clinicalevaluation of extract of Andrographis paniculata (KalmCold) inpatients with uncomplicated upper respiratory tract infection.
Saxena RC, Singh R, Kumar P, Yadav SC, Negi MP, Saxena VS,Joshua AJ, Vijayabalaji V, Goudar KS, Venkateshwarlu K, Amit A.
Phytomedicine. 2010 Mar;17(3-4):178-85.
Pubmed: http://www.ncbi.nlm.nih.gov/pubmed/20092985
- Controlled clinical study of standardized Andrographispaniculata extract in common cold - a pilot trial
J. Melchior, S. Palm, G. Wikman
Phytomedicine Volume 3, Issue 4, February 1997, Pages 315–318
Science Direct:http://www.sciencedirect.com/science/article/pii/S0944711397800025 - Prevention of common colds with Andrographis paniculatadried extract. A Pilot double blind trial.
Cáceres DD, Hancke JL, Burgos RA, Wikman GK.
Phytomedicine. 1997 Jun;4(2):101-4.
Science Direct: http://www.ncbi.nlm.nih.gov/pubmed/23195395 - A double-blind study with a new monodrug Kan Jang:Decrease of symptoms and improvement in the recovery from commoncolds
Juan Hancke, Rafael Burgos, Dante Caceres, Georg Wikman
Phytotherapy Research Volume 9, Issue 8, pages 559–562,December 1995
Wiley Online Library:http://onlinelibrary.wiley.com/doi/10.1002/ptr.2650090804/abstract
- A double blind, placebo-controlled study of Andrographispaniculata fixed combination Kan Jang in the treatment of acuteupper respiratory tract infections including sinusitis.
Gabrielian ES, Shukarian AK, Goukasova GI, Chandanian GL,Panossian AG, Wikman G, Wagner H.
Phytomedicine. 2002 Oct;9(7):589-97.
Pubmed: http://www.ncbi.nlm.nih.gov/pubmed/12487322
- Comparative controlled study of Andrographis paniculatafixed combination, Kan Jang and an Echinacea preparation asadjuvant, in the treatment of uncomplicated respiratory disease inchildren.
Spasov AA, Ostrovskij OV, Chernikov MV, Wikman G.
Phytother Res. 2004 Jan;18(1):47-53.
Pubmed: http://www.ncbi.nlm.nih.gov/pubmed/14750201
The health claims that feature on our website in relation to the plants contained in our products are compliant with the list of health claims awaiting final assessment by the Community authorities (cf. website of the European Commission: http://ec.europa.eu/nuhclaims/). However, they may be subject to modification following their assessment by the national competent authorities.
The health claims relating to other nutrients or substances contained in our products that feature on our site are compliant with Regulation No. 432/2012 of the Commission of 16 May 2012 which establishes a list of authorised health claims authorised in relation to food products, other than those in reference to the reduction of the risk of disease as well as community-based development and child health (cf. website of the European Commission: http://ec.europa.eu/nuhclaims/).